Statistics from Altmetric.com
Commentary on: OpenUrl
Misoprostol is a safe and effective prophylactic option for postpartum haemorrhage (PPH). An international consensus exists in support of orally administered 600 mcg misoprostol, when oxytocin is not available or feasible,1 but most head-to-head trials suggest a lesser efficacy of misoprostol compared with that of oxytocin. Differing doses and routes of administration have also been explored in small inconclusive studies.2
A double-blind randomised controlled trial was conducted at a hospital in India to explore whether a powdered formulation of 400 mcg misoprostol sublingually was more effective than 10 IU oxytocin intramuscularly in reducing mean blood loss and PPH ≥500 ml. Misoprostol tablets were crushed, wrapped in paper and weighed. The placebo was starch. …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.